Stanford University — Coronavirus Drug Research (February 2020) (Jeffrey Glenn)

Organization Name 
Award Date 
2/2020
Grant Amount 
$165,000
Purpose 
To support work to test antiviral drug candidates against the COVID-19 coronavirus.
Topic (focus area) 

Grant investigators: Chris Somerville and Heather Youngs

This page was reviewed but not written by the grant investigators. Stanford University staff also reviewed this page prior to publication.

Open Philanthropy recommended an unrestricted grant of $165,000 to Stanford University to support work led by Stanford Professors Jeffrey Glenn and Rhiju Das and University of North Carolina Professor Ralph Baric, which they intend to use to test antiviral drug candidates against the COVID-19 coronavirus.

This falls within our work on scientific research, and specifically within our interest in science supporting biosecurity and pandemic preparedness.